CureVac N.V. (CVAC) announces AGM results

CureVac N.V. (NASDAQ: CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of the Company's Annual General Meeting.

The shareholders of the Company voted in favor of all proposals. These proposals included the appointment of Axel Sven Malkomes as a member of the Management Board, effective June 24, 2025. Additionally, Jean Stéphenne, Debra Barker, Craig A. Tooman, as well as Klaus Schollmeier were reappointed as members of the Supervisory Board, Mehdi Shahidi was appointed as a new member of the Supervisory Board, effective June 24, 2025. KPMG Accountants N.V. was reappointed as the external auditors for the financial year 2026.

A table containing tabulations of the votes casted is expected to be released in the coming days.

You May Also Be Interested In

• Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
• Chevron reaches deal for two fields in Venezuela's Orinoco belt
• NIQ and Similarweb to build AI commerce measurement tool